Edesa Biotech (EDSA) Gross Margin (2013 - 2020)
Edesa Biotech (EDSA) recorded Gross Margin of -362.80% in fiscal Q4 2020 (quarter ended Sep 30, 2020), down 461.46 percentage points from the prior quarter.
Powered by 
Analysis
Edesa Biotech (EDSA) Gross Margin (2013 - 2020) Analysis & Trends
For FY2020 (ended Sep 30, 2020), Edesa Biotech reported Gross Margin of 94.65%, up 19.30 percentage points from FY2019.
- Annual Gross Margin has increased for three straight fiscal years, with a five-year change of +71.20 percentage points (FY2015 to FY2020).
- Across earlier fiscal years, Gross Margin came in at 75.35% in FY2019 (+38.28 pp), 37.07% in FY2018 (+46.60 pp), -9.53% in FY2017 (-45.16 pp) and 35.63% in FY2016 (+12.19 pp).
- The fiscal Q4 2020 figure is the lowest quarterly Gross Margin since fiscal Q4 2017.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 744.99 percentage points in fiscal Q4 2018, against a drop of 737.92 percentage points in fiscal Q4 2017 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 98.66% (Q3 2020), 90.92% (Q2 2020) and 96.50% (Q1 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Edesa Biotech | 35.16 Mn | 35.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -362.80% |
| Jun 30, 2020 | 98.66% |
| Mar 31, 2020 | 90.92% |
| Dec 31, 2019 | 96.50% |
| Jun 30, 2019 | 100.00% |
| Sep 30, 2018 | 64.47% |
| Mar 31, 2018 | -2.45% |
| Dec 31, 2017 | 86.33% |
| Sep 30, 2017 | -680.52% |
| Jun 30, 2017 | -277.73% |
| Mar 31, 2017 | -13.37% |
| Dec 31, 2016 | 44.62% |
| Sep 30, 2016 | 57.40% |
| Jun 30, 2016 | 33.74% |
| Mar 31, 2016 | 17.60% |
| Dec 31, 2015 | 36.07% |
| Sep 30, 2015 | 95.12% |
| Jun 30, 2015 | -47.07% |
| Mar 31, 2015 | -29.57% |
| Dec 31, 2014 | 54.89% |
API Access
Edesa Biotech Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();